Andreas Schuil

Andreas Schuil is a seasoned professional in the biopharmaceutical industry, currently serving as the General Manager for BeNeLux and EMEA Partner Markets at Orchard Therapeutics since December 2019. Schuil also holds a position as a Board Member for the Dutch Orphan Drug Committee, addressing challenges in delivering rapid access to orphan drugs. Previous roles include Senior Brand Director for Europe at Sanofi Genzyme, where responsibilities spanned multiple rare disease products, along with significant positions at Genzyme, including Business Unit Director for Rare Diseases in the Benelux region. Schuil obtained an International Executive MBA from Rotterdam School of Management and an MSc in Biopharmaceutical Sciences from Universiteit Leiden.